Literature DB >> 30243726

In vitro large scale production of megakaryocytes to functional platelets from human hematopoietic stem cells.

Pasupuleti Santhosh Kumar1, Chodimella Chandrasekhar2, Lokanathan Srikanth1, Potukuchi Venkata Gurunadha Krishna Sarma3.   

Abstract

Megakaryocytopoiesis results in the formation of platelets, which are essential for hemostasis. Decreased production or increased destruction of platelets can cause thrombocytopenia, in which platelet transfusion is the mode of treatment. The present study is aimed in generation of megakaryocytes (MKs) and platelet from human hematopoietic stem cells (HSCs). The purity of HSCs was assessed through Flow cytometry and immunocytochemistry (ICC) studies. These pure HSCs were induced with thrombopoietin (TPO), similarly with Andrographis paniculata extract (APE) for 21 days to generate MKs. The APE is mainly composed of andrographolide which stimulates TPO from the liver, and this binds to CD110 present on the surface of HSCs and triggers the proliferation of HSCs and initiate higher MKs population subsequently, a large number of platelets. The results of the present study showed increased proliferation of HSCs grown in the presence of APE and revealed a high population of CD41a and CD42b positive MKs as enumerated by Flow cytometry compared with TPO induced MKs. These results also concurred with qRT-PCR and western blot analysis. The scanning electron microscopy (SEM) revealed the morphology of differentiated MKs and platelets were similar to human blood platelets. The differentiated MKs in APE exhibited polyploidy up to 32 N while TPO induced MKs showed polyploidy of 8 N, these results corroborated with colony forming unit assay. On thrombin stimulation, high expression of P-selectin (CD62p) and fibrinogen binding were detected in APE induced platelets. Autologous transplantation of platelets generated from APE may be a useful option in thrombocytopenia condition.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Andrographis paniculata extract (APE); CD41a; CD42b; HSCs; MKs; Platelets

Mesh:

Substances:

Year:  2018        PMID: 30243726     DOI: 10.1016/j.bbrc.2018.09.090

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.

Authors:  Alessandro Allegra; Mario Di Gioacchino; Alessandro Tonacci; Caterina Musolino; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

2.  Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients.

Authors:  Chodimella Chandrasekhar; Pasupuleti Santhosh Kumar; Potukuchi Venkata Gurunadha Krishna Sarma
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

3.  Using genome editing to engineer universal platelets.

Authors:  Moyra Lawrence; Annett Mueller; Cedric Ghevaert
Journal:  Emerg Top Life Sci       Date:  2019-05-31

4.  Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.

Authors:  Rong Qu; Yun Ling; Yi-Hui-Zhi Zhang; Li-Ya Wei; Xiao Chen; Xu-Mian Li; Xuan-Yong Liu; Han-Mian Liu; Zhi Guo; Hua Ren; Qiang Wang
Journal:  J Med Virol       Date:  2020-03-26       Impact factor: 2.327

Review 5.  Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP.

Authors:  Moyra Lawrence; Amanda Evans; Thomas Moreau; Marta Bagnati; Matthew Smart; Enas Hassan; Jahid Hasan; Monica Pianella; Julie Kerby; Cedric Ghevaert
Journal:  NPJ Regen Med       Date:  2021-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.